FDA Approves First Drug for Postpartum Depression, Brexanolone (Zulesso)

WEDNESDAY, March 20, 2019 -- Postpartum depression is a common and often devastating condition for new mothers, but the U.S. Food and Drug Administration on Tuesday approved the first drug to help combat it. The drug, Zulesso (brexanolone), is...
Source: Drugs.com - Daily MedNews - Category: General Medicine Source Type: news